Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data

Drug Saf. 2024 Sep;47(9):841-842. doi: 10.1007/s40264-024-01457-x. Epub 2024 Jun 14.

Author

Ursula Winterfeld¹

Affiliation

¹ Swiss Teratogen Information Service (STIS) and Clinical Pharmacology Service, Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland. ursula.winterfeld@chuv.ch.

PMID: 38877378
DOI: 10.1007/s40264-024-01457-x

No abstract available

Publication types

Editorial
Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Antibodies, Monoclonal, Humanized* / therapeutic use
Evidence Gaps
Female
Humans
Pregnancy
Pregnancy Complications / drug therapy

Substances

Antibodies, Monoclonal, Humanized